NASDAQ

Phathom Pharmaceuticals, Inc. (PHAT)

♥ 608 Thanks from members

Live price chart, market sentiment, and community perspectives for Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: PharmaceuticalsFounder: Phathom Pharmaceuticals Founding TeamLeadership: Terrie Curran (CEO)Leadership: Murtaza Shah (CFO)Holder: FMR LLCHolder: Deep Track CapitalHolder: BlackRockVoquezna (vonoprazan)GI Disease Treatments#PHAT#Phathom Pharmaceuticals#Biopharma#Voquezna#Gastroenterology